Using Precision Medicine in Clinical Trials to Advancing Therapeutics for both Degenerative & Rare Mitochondrial Diseases

Time: 9:30 am
day: Day Two

Details:

  • Assessing clinical data with biomarker-correlated outcomes of ANAVEX2-73 (blarcamesine) in Alzheimer’s, Parkinson’s, and Rett Syndrome
  • Reviewing mechanistic analysis of involvement of mitochondrial function

Speakers: